CLIMB BIO, INC. Related Party Transaction, Amounts of Transaction
CLIMB BIO, INC. (CLYM) reported Related Party Transaction, Amounts of Transaction of $29.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Notes
us-gaap:RelatedPartyTransactionAmountsOfTransaction · last filed 2022-08-15
- CLIMB BIO, INC. related party transaction, amounts of transaction for the quarter ending 2022-06-30 was $29.00K, a 90.33% decline year-over-year.
- CLIMB BIO, INC. related party transaction, amounts of transaction for the quarter ending 2022-03-31 was $100.00K, a 75.00% decline year-over-year.
- CLIMB BIO, INC. related party transaction, amounts of transaction for the quarter ending 2021-12-31 was $300.00K, a 0.00% change year-over-year.
- CLIMB BIO, INC. related party transaction, amounts of transaction for the quarter ending 2021-09-30 was $300.00K, a 1664.71% increase year-over-year.
- CLIMB BIO, INC. related party transaction, amounts of transaction for fiscal 2021 was $1.30M, a 116.67% increase from fiscal 2020.
- CLIMB BIO, INC. related party transaction, amounts of transaction for fiscal 2020 was $600.00K.
| Period end | Related Party Transaction, Amounts of Transaction 3 month | Related Party Transaction, Amounts of Transaction 6 month | Related Party Transaction, Amounts of Transaction 9 month | Related Party Transaction, Amounts of Transaction 12 month |
|---|---|---|---|---|
| 2022-06-30 | $29.00K 10-Q · filed 2022-08-15 | $200.00K 10-Q · filed 2022-08-15 | $429.00K derived: sum of 3 quarters · filed 2022-08-15 | $729.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | $100.00K 10-Q · filed 2022-05-16 | $400.00K derived: sum of 2 quarters · filed 2022-05-16 | $700.00K derived: sum of 3 quarters · filed 2022-05-16 | $1.00M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $600.00K derived: sum of 2 quarters · filed 2022-03-07 | $900.00K derived: sum of 3 quarters · filed 2022-08-15 | $1.30M 10-K · filed 2022-03-07 |
| 2021-09-30 | $300.00K 10-Q · filed 2021-11-08 | $600.00K derived: sum of 2 quarters · filed 2022-08-15 | $1.00M 10-Q · filed 2021-11-08 | $1.30M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-06-30 | $300.00K 10-Q · filed 2022-08-15 | $700.00K 10-Q · filed 2022-08-15 | $1.00M derived: sum of 3 quarters · filed 2022-08-15 | $1.02M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $400.00K 10-Q · filed 2022-05-16 | $700.00K derived: sum of 2 quarters · filed 2022-05-16 | $717.00K derived: sum of 3 quarters · filed 2022-05-16 | $817.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $317.00K derived: sum of 2 quarters · filed 2022-03-07 | $417.00K derived: sum of 3 quarters · filed 2022-03-07 | $600.00K 10-K · filed 2022-03-07 |
| 2020-09-30 | $17.00K 10-Q · filed 2021-11-08 | $117.00K derived: sum of 2 quarters · filed 2021-11-08 | $300.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $100.00K 10-Q · filed 2021-09-13 | $300.00K 10-Q · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |